YASER S BASSEL
Allopathic & Osteopathic Physicians|Urology PALM HARBOR, FL NPI 1376740415
Browse related groups: Allopathic & Osteopathic Physicians|Urology FL PFIZER INC. All categories
General Payments — all program years on this page
$12,657.66
- Category: General Payments
- Program years: PY2018–2024
- Record count: 406
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,608.39 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,658.39 | 60 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $950.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $972.54 | 2 |
| Axonics Modulation Technologies, Inc. | $588.92 | 12 |
| ABBVIE INC. | $153.39 | 7 |
| COLOPLAST CORP | $140.68 | 5 |
| Sumitomo Pharma America, Inc. | $62.08 | 3 |
| Myriad Genetic Laboratories, Inc. | $60.10 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $60.02 | 3 |
| Dendreon Pharmaceuticals LLC | $57.89 | 2 |
| Astellas Pharma US Inc | $56.79 | 3 |
| Endo USA, Inc. | $50.32 | 2 |
| Teleflex LLC | $47.76 | 2 |
| UROGEN PHARMA, INC. | $43.13 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $38.09 | 2 |
| Telix Pharmaceuticals | $31.93 | 1 |
| CIVCO Medical Instruments | $26.62 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $25.26 | 1 |
| Medtronic, Inc. | $24.82 | 1 |
| Endo Pharmaceuticals Inc. | $24.31 | 1 |
| Acerta Pharma LLC | $22.16 | 1 |
| Janssen Biotech, Inc. | $20.35 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $20.27 | 1 |
| PROCEPT BioRobotics Corporation | $20.06 | 1 |
| Photocure Inc | $15.93 | 1 |
| Ferring Pharmaceuticals Inc. | $15.74 | 1 |
| Verity Pharmaceuticals Inc. | $15.26 | 1 |
| Merck Sharp & Dohme Corporation | $13.97 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.